AGREEMENT AND PLAN OF MERGER by and among BIOTIME, INC., PATRICK MERGER SUB, INC. and Asterias biotherapeutics, inc. dated as of November 7, 2018Agreement and Plan of Merger • November 8th, 2018 • Biotime Inc • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 8th, 2018 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER, dated November 7, 2018 (this “Agreement”), is made by and among BioTime, Inc., a California corporation (“BioTime”), Patrick Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of BioTime (“Merger Sub”), and Asterias Biotherapeutics, Inc., a Delaware corporation (“Asterias”). BioTime, Merger Sub and Asterias each are sometimes referred to herein as a “Party” and collectively as the “Parties.” Capitalized terms used in this Agreement but not otherwise defined shall be given the meanings ascribed to them in Section 9.5 of this Agreement.
AGREEMENT AND PLAN OF MERGER by and among BIOTIME, INC., PATRICK MERGER SUB, INC. and ASTERIAS BIOTHERAPEUTICS, INC. dated as of November 7, 2018Agreement and Plan of Merger • November 8th, 2018 • Asterias Biotherapeutics, Inc. • Biological products, (no disgnostic substances) • Delaware
Contract Type FiledNovember 8th, 2018 Company Industry JurisdictionThis AGREEMENT AND PLAN OF MERGER, dated November 7, 2018 (this “Agreement”), is made by and among BioTime, Inc., a California corporation (“BioTime”), Patrick Merger Sub, Inc., a Delaware corporation and a direct wholly owned subsidiary of BioTime (“Merger Sub”), and Asterias Biotherapeutics, Inc., a Delaware corporation (“Asterias”). BioTime, Merger Sub and Asterias each are sometimes referred to herein as a “Party” and collectively as the “Parties.” Capitalized terms used in this Agreement but not otherwise defined shall be given the meanings ascribed to them in Section 9.5 of this Agreement.